Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2989

1.

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials.

Kim YS, Oka S, Chetchotisakd P, Clarke A, Supparatpinyo K, Avihingsanon A, Ratanasuwan W, Kiertiburanakul S, Ruxrungtham K, Yang S, Guo S, Liu Y, Das M, Tran D, McColl D, Corales R, Nguyen C, Piontkowsky D.

HIV Res Clin Pract. 2019 Jul 8:1-9. doi: 10.1080/15284336.2019.1589232. [Epub ahead of print]

PMID:
31303140
2.

Professionals' accounts of genetic testing in adoption: a qualitative study.

Arribas-Ayllon M, Clarke A, Shelton K.

Arch Dis Child. 2019 Jul 11. pii: archdischild-2019-316911. doi: 10.1136/archdischild-2019-316911. [Epub ahead of print]

PMID:
31296598
Free Article
3.

APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression.

Mohamed NE, Hay T, Reed KR, Smalley MJ, Clarke AR.

BMC Cancer. 2019 Jul 10;19(1):677. doi: 10.1186/s12885-019-5867-y.

PMID:
31291912
Free Article
4.

Decreased tibial nerve movement in patients with failed back surgery syndrome and persistent leg pain.

Shum G, Cinnamond S, Hutton M, Chan D, Chauhan R, Bloxham S, Choy S, Cheung R, Eldabe S, Clarke A.

Eur Spine J. 2019 Jul 9. doi: 10.1007/s00586-019-06056-4. [Epub ahead of print]

PMID:
31290026
5.

Letter in Response to Tibben et al., Risk Assessment for Huntington's Disease for (Future) Offspring Requires Offering Preconceptional CAG Analysis to Both Partners.

Quarrell OW, Delatycki MB, Clarke AJ, Lahiri N, Craufurd D, Miedzybrodzka Z, MacLeod R, Renwick P, Tomlinson C.

J Huntingtons Dis. 2019 Jun 29. doi: 10.3233/JHD-190360. [Epub ahead of print] No abstract available.

PMID:
31282428
6.

European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death.

Fellmann F, van El CG, Charron P, Michaud K, Howard HC, Boers SN, Clarke AJ, Duguet AM, Forzano F, Kauferstein S, Kayserili H, Lucassen A, Mendes Á, Patch C, Radojkovic D, Rial-Sebbag E, Sheppard MN, Tassé AM, Temel SG, Sajantila A, Basso C, Wilde AAM, Cornel MC; on behalf of European Society of Human Genetics, European Council of Legal Medicine, European Society of Cardiology working group on myocardial and pericardial diseases, European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Association for European Cardiovascular Pathology.

Eur J Hum Genet. 2019 Jun 24. doi: 10.1038/s41431-019-0445-y. [Epub ahead of print]

PMID:
31235869
7.

Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation to Mouse Dams in Gestation Does Not Affect Fetal Weight Variation of Offspring or Placental Development (P09-003-19).

Clarke A, Horn N, Shurson G, Faulk C, Johnston L.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz033.P09-003-19. doi: 10.1093/cdn/nzz033.P09-003-19. eCollection 2019 Jun.

8.

Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival.

Tessier-Cloutier B, Twa DD, Baecklund E, Gascoyne R, Johnson NA, Backlin C, Kamen DL, Clarke AE, Ramsey-Goldman R, Lee JL, Farinha P, Bernatsky S.

Lupus Sci Med. 2019 May 4;6(1):e000324. doi: 10.1136/lupus-2019-000324. eCollection 2019.

9.

In Vivo Assessment of Thoracic Vertebral Shape From MRI Data Using a Shape Model.

Meakin JR, Hopkins SJ, Clarke A.

Spine Deform. 2019 Jul;7(4):517-524. doi: 10.1016/j.jspd.2018.10.005.

PMID:
31202366
10.

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors.

Lin J, Lu W, Caravella JA, Campbell AM, Diebold RB, Ericsson A, Fritzen E, Gustafson GR, Lancia DR Jr, Shelekhin T, Wang Z, Castro J, Clarke A, Gotur D, Josephine HR, Katz M, Diep H, Kershaw M, Yao L, Kauffman G, Hubbs SE, Luke GP, Toms AV, Wang L, Bair KW, Barr KJ, Dinsmore C, Walker D, Ashwell S.

J Med Chem. 2019 Jul 8. doi: 10.1021/acs.jmedchem.9b00362. [Epub ahead of print]

PMID:
31199148
11.

No evidence for a common factor underlying visual abilities in healthy older people.

Shaqiri A, Pilz KS, Cretenoud AF, Neumann K, Clarke A, Kunchulia M, Herzog MH.

Dev Psychol. 2019 Jun 13. doi: 10.1037/dev0000740. [Epub ahead of print]

PMID:
31192641
12.

Genome Sequence of Kordia sp. Strain SMS9 Identified in a Non-Axenic Culture of the Diatom Skeletonema marinoi.

Pinder MIM, Johansson ON, Almstedt A, Kourtchenko O, Clarke AK, Godhe A, Töpel M.

J Genomics. 2019 May 9;7:46-49. doi: 10.7150/jgen.35061. eCollection 2019.

13.

EEG development in Attention Deficit Hyperactivity Disorder: From child to adult.

Clarke AR, Barry RJ, Johnstone SJ, McCarthy R, Selikowitz M.

Clin Neurophysiol. 2019 Aug;130(8):1256-1262. doi: 10.1016/j.clinph.2019.05.001. Epub 2019 May 9.

PMID:
31163371
14.

KEY EXPERIENCES OF PRIMARY SOCIAL GROUPS IN UNSPECIFIED KIDNEY DONATION.

Clarke A, Mitchell A, Williams L, Kirk A, Auburn T, Price L, Shorrock J, Chester L.

J Ren Care. 2019 Jun 3. doi: 10.1111/jorc.12276. [Epub ahead of print]

PMID:
31157956
15.

Development of a High Throughput Screen for the Identification of Inhibitors of Peptidoglycan O-Acetyltransferases, New Potential Antibacterial Targets.

Brott AS, Jones CS, Clarke AJ.

Antibiotics (Basel). 2019 May 27;8(2). pii: E65. doi: 10.3390/antibiotics8020065.

16.

Co-creating a knowledge base in the "22q11.2 deletion syndrome" community.

Rizzo R, Van den Bree M, Challenger A, Cuthbert A, Ayllon MA, Clarke A, Thompson R.

J Community Genet. 2019 May 25. doi: 10.1007/s12687-019-00425-8. [Epub ahead of print]

PMID:
31129779
17.

Genetic and environmental susceptibility to food allergy in a registry of twins.

Kivistö JE, Clarke A, Dery A, De Schryver S, Shand G, Huhtala H, Mäkelä MJ, Asai Y, Nadeau K, Harada L, Chan ES, Ben-Shoshan M.

J Allergy Clin Immunol Pract. 2019 May 24. pii: S2213-2198(19)30471-4. doi: 10.1016/j.jaip.2019.05.016. [Epub ahead of print] No abstract available.

PMID:
31129075
18.

Timing of Fistula Creation and the Probability of Catheter-Free Use: A Cohort Study.

Clarke A, Ravani P, Oliver MJ, Hiremath S, Blake PG, Moist LM, Garg AX, Lam NN, Quinn RR.

Can J Kidney Health Dis. 2019 May 7;6:2054358119843139. doi: 10.1177/2054358119843139. eCollection 2019.

19.

Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in Systemic Lupus Erythematosus.

Odhams CA, Roberts AL, Vester SK, Duarte CST, Beales CT, Clarke AJ, Lindinger S, Daffern SJ, Zito A, Chen L, Jones LL, Boteva L, Morris DL, Small KS, Fernando MMA, Cunninghame Graham DS, Vyse TJ.

Nat Commun. 2019 May 15;10(1):2164. doi: 10.1038/s41467-019-10106-2.

20.

Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa.

Idowu A, Mzukwa A, Harrison U, Palamides P, Haas R, Mbao M, Mamdoo R, Bolon J, Jolaiya T, Smith S, Ally R, Clarke A, Njom H.

BMC Gastroenterol. 2019 May 14;19(1):73. doi: 10.1186/s12876-019-0986-0.

21.

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours.

Ordonez LD, Hay T, McEwen R, Polanska UM, Hughes A, Delpuech O, Cadogan E, Powell S, Dry J, Tornillo G, Silcock L, Leo E, O'Connor MJ, Clarke AR, Smalley MJ.

Oncotarget. 2019 Apr 5;10(27):2586-2606. doi: 10.18632/oncotarget.26830. eCollection 2019 Apr 5.

22.

Beyond Bouma's window: How to explain global aspects of crowding?

Doerig A, Bornet A, Rosenholtz R, Francis G, Clarke AM, Herzog MH.

PLoS Comput Biol. 2019 May 10;15(5):e1006580. doi: 10.1371/journal.pcbi.1006580. eCollection 2019 May.

23.

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.

Wohl DA, Yazdanpanah Y, Baumgarten A, Clarke A, Thompson MA, Brinson C, Hagins D, Ramgopal MN, Antinori A, Wei X, Acosta R, Collins SE, Brainard D, Martin H.

Lancet HIV. 2019 Jun;6(6):e355-e363. doi: 10.1016/S2352-3018(19)30077-3. Epub 2019 May 5.

PMID:
31068270
24.

How service-users with intellectual disabilities understand challenging behaviour and approaches to managing it.

Clarke A, Dagnan D, Smith IC.

J Appl Res Intellect Disabil. 2019 May 7. doi: 10.1111/jar.12612. [Epub ahead of print]

PMID:
31066173
25.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group.

Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2.

26.

Analysis of the Phenotypes in the Rett Networked Database.

Frullanti E, Papa FT, Grillo E, Clarke A, Ben-Zeev B, Pineda M, Bahi-Buisson N, Bienvenu T, Armstrong J, Roche Martinez A, Mari F, Nissenkorn A, Lo Rizzo C, Veneselli E, Russo S, Vignoli A, Pini G, Djuric M, Bisgaard AM, Ravn K, Bosnjak VM, Hayek J, Khajuria R, Montomoli B, Cogliati F, Pintaudi M, Hadzsiev K, Craiu D, Voinova V, Djukic A, Villard L, Renieri A.

Int J Genomics. 2019 Mar 27;2019:6956934. doi: 10.1155/2019/6956934. eCollection 2019.

27.

Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort.

Gabrielli S, Clarke A, Morris J, Eisman H, Gravel J, Enarson P, Chan ES, O'Keefe A, Porter R, Lim R, Yanishevsky Y, Gerdts J, Adatia A, LaVieille S, Zhang X, Ben-Shoshan M.

J Allergy Clin Immunol Pract. 2019 Apr 26. pii: S2213-2198(19)30391-5. doi: 10.1016/j.jaip.2019.04.018. [Epub ahead of print]

PMID:
31035000
28.

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.

Amlani A, Choi MY, Tarnopolsky M, Brady L, Clarke AE, Garcia-De La Torre I, Mahler M, Schmeling H, Barber CE, Jung M, Fritzler MJ.

Front Immunol. 2019 Apr 9;10:745. doi: 10.3389/fimmu.2019.00745. eCollection 2019.

29.

Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial.

Miltz AR, Lampe FC, Bacchus LJ, McCormack S, Dunn D, White E, Rodger A, Phillips AN, Sherr L, Clarke A, McOwan A, Sullivan A, Gafos M.

BMC Public Health. 2019 Apr 25;19(1):431. doi: 10.1186/s12889-019-6757-6.

31.

Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study.

Sewell J, Cambiano V, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Rodger AJ.

Int J Drug Policy. 2019 Jun;68:54-61. doi: 10.1016/j.drugpo.2019.03.021. Epub 2019 Apr 15.

32.

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338. [Epub ahead of print]

PMID:
30988130
33.

Can a continuous quality improvement program create culturally safe emergency departments for Aboriginal people in Australia? A multiple baseline study.

Gadsden T, Wilson G, Totterdell J, Willis J, Gupta A, Chong A, Clarke A, Winters M, Donahue K, Posenelli S, Maher L, Stewart J, Gardiner H, Passmore E, Cashmore A, Milat A.

BMC Health Serv Res. 2019 Apr 11;19(1):222. doi: 10.1186/s12913-019-4049-6.

34.

Skeletonema marinoi as a new genetic model for marine chain-forming diatoms.

Johansson ON, Töpel M, Pinder MIM, Kourtchenko O, Blomberg A, Godhe A, Clarke AK.

Sci Rep. 2019 Apr 2;9(1):5391. doi: 10.1038/s41598-019-41085-5.

35.

Relationships between illness representations, physical activity and depression in chronic kidney disease.

Nah R, Robertson N, Niyi-Odumosu FA, Clarke AL, Bishop NC, Smith AC.

J Ren Care. 2019 Jun;45(2):74-82. doi: 10.1111/jorc.12274. Epub 2019 Apr 1.

PMID:
30938078
36.

Barriers and facilitators for engagement and implementation of exercise in end-stage kidney disease: Future theory-based interventions using the Behavior Change Wheel.

Clarke AL, Jhamb M, Bennett PN.

Semin Dial. 2019 Jul;32(4):308-319. doi: 10.1111/sdi.12787. Epub 2019 Apr 1.

PMID:
30937975
37.

Response to Middleton KR et als. Yoga and SLE.

Lee J, Pineau CA, Da Costa D, Clarke AE, Fortin PR, Neville C, Neville A, Bernatsky S.

Complement Ther Med. 2019 Apr;43:311. doi: 10.1016/j.ctim.2019.02.019. Epub 2019 Feb 28. No abstract available.

PMID:
30935550
38.

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.

Gupta SK, Post FA, Arribas JR, Eron JJ Jr, Wohl DA, Clarke AE, Sax PE, Stellbrink HJ, Esser S, Pozniak AL, Podzamczer D, Waters L, Orkin C, Rockstroh JK, Mudrikova T, Negredo E, Elion RA, Guo S, Zhong L, Carter C, Martin H, Brainard D, SenGupta D, Das M.

AIDS. 2019 Jul 15;33(9):1455-1465. doi: 10.1097/QAD.0000000000002223.

PMID:
30932951
39.

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial.

White E, Dunn DT, Desai M, Gafos M, Kirwan P, Sullivan AK, Clarke A, McCormack S; PROUD study group.

Sex Transm Infect. 2019 Mar 27. pii: sextrans-2018-053808. doi: 10.1136/sextrans-2018-053808. [Epub ahead of print]

40.

Indole Synthesis Using Silver Catalysis.

Clarke AK, Ho HE, Rossi-Ashton JA, Taylor RJK, Unsworth WP.

Chem Asian J. 2019 Jun 3;14(11):1900-1911. doi: 10.1002/asia.201900309. Epub 2019 Apr 25. Review.

PMID:
30908897
41.

A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Wadrup F, Holden S, MacLeod R, Miedzybrodzka Z, Németh AH, Owens S, Pasalodos S, Quarrell O, Clarke AJ; UK Huntington’s Disease Predictive Testing Consortium.

Eur J Hum Genet. 2019 Aug;27(8):1215-1224. doi: 10.1038/s41431-019-0375-8. Epub 2019 Mar 19.

PMID:
30890781
42.

Assays for the Enzymes Catalyzing the O-Acetylation of Bacterial Cell Wall Polysaccharides.

Brott AS, Sychantha D, Clarke AJ.

Methods Mol Biol. 2019;1954:115-136. doi: 10.1007/978-1-4939-9154-9_10.

PMID:
30864128
43.

Vital sign monitoring with continuous pulse oximetry and wireless clinical notification after surgery (the VIGILANCE pilot study)-a randomized controlled pilot trial.

Paul JE, Chong MA, Buckley N, Harsha P, Shanthanna H, Tidy A, Buckley D, Clarke A, Young C, Wong T, Vanniyasingam T, Thabane L.

Pilot Feasibility Stud. 2019 Feb 26;5:36. doi: 10.1186/s40814-019-0415-8. eCollection 2019.

44.

Assessment of priority tobacco additives per the requirements in the EU Tobacco Products Directive (2014/40/EU): Part 2: Smoke chemistry and in vitro toxicology.

Stabbert R, Ghosh D, Clarke A, Miller J, Collard J, Crooks I, Tafin Djoko D, Larroque S, Jaccard G, Roemer E, Park CH, Esposito M.

Regul Toxicol Pharmacol. 2019 Jun;104:163-199. doi: 10.1016/j.yrtph.2019.03.002. Epub 2019 Mar 8.

45.

Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy.

Freeman K, Willis BH, Fraser H, Taylor-Phillips S, Clarke A.

BMJ Open. 2019 Mar 8;9(3):e027428. doi: 10.1136/bmjopen-2018-027428.

46.

Energy Flow in Growth and Production.

Clarke A.

Trends Ecol Evol. 2019 Jun;34(6):502-509. doi: 10.1016/j.tree.2019.02.003. Epub 2019 Mar 1. Review.

PMID:
30832986
47.

Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.

Bener A, Al-Mulla M, Clarke A.

Int J Appl Basic Med Res. 2019 Jan-Mar;9(1):20-26. doi: 10.4103/ijabmr.IJABMR_42_18.

48.

A constructivist grounded theory study to explore compassion through the perceptions of individuals who have experienced nursing care.

Straughair C, Clarke A, Machin A.

J Adv Nurs. 2019 Jul;75(7):1527-1538. doi: 10.1111/jan.13987. Epub 2019 Apr 5.

PMID:
30816572
49.

Nonlinear scaling effects in the stiffness of soft cellular structures.

Wyatt H, Safar A, Clarke A, Evans SL, Mihai LA.

R Soc Open Sci. 2019 Jan 16;6(1):181361. doi: 10.1098/rsos.181361. eCollection 2019 Jan.

50.

Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 1: Background, approach, and summary of findings.

Simms L, Clarke A, Paschke T, Manson A, Murphy J, Stabbert R, Esposito M, Ghosh D, Roemer E, Martinez J, Freiesleben J, Kim HK, Lindegaard T, Scharfe M, Vincze I, Vlachos P, Wigotzki D, Pollner G, Lutz R.

Regul Toxicol Pharmacol. 2019 Jun;104:84-97. doi: 10.1016/j.yrtph.2019.02.011. Epub 2019 Feb 21.

Supplemental Content

Loading ...
Support Center